Benjamin Edwards Inc Crispr Therapeutics Ag Transaction History

Benjamin Edwards Inc

  • $520 Million
  • Q2 2024

A detailed history of Benjamin Edwards Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Benjamin Edwards Inc holds 238 shares of CRSP stock, worth $11,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
238
Previous 369 35.5%
Holding current value
$11,802
Previous $25,000 48.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$51.17 - $68.18 $6,703 - $8,931
-131 Reduced 35.5%
238 $13,000
Q1 2024

Apr 29, 2024
BUY
$60.67 - $89.12 $1,820 - $2,673
30 Added 8.85%
369 $25,000
Q4 2023

Feb 06, 2024
SELL
$38.62 - $72.18 $6,372 - $11,909
-165 Reduced 32.74%
339 $21,000
Q3 2023

Nov 13, 2023
BUY
$45.39 - $59.0 $590 - $767
13 Added 2.65%
504 $23,000
Q2 2023

Aug 15, 2023
SELL
$43.47 - $67.77 $2,912 - $4,540
-67 Reduced 12.01%
491 $28,000
Q1 2023

Apr 27, 2023
BUY
$41.0 - $56.12 $1,230 - $1,683
30 Added 5.68%
558 $25,000
Q4 2022

Feb 07, 2023
BUY
$39.19 - $65.67 $4,193 - $7,026
107 Added 25.42%
528 $21,000
Q3 2022

Oct 28, 2022
SELL
$61.1 - $83.78 $4,765 - $6,534
-78 Reduced 15.63%
421 $28,000
Q2 2022

Aug 12, 2022
BUY
$43.23 - $73.83 $821 - $1,402
19 Added 3.96%
499 $30,000
Q1 2022

May 04, 2022
BUY
$53.19 - $79.24 $531 - $792
10 Added 2.13%
480 $30,000
Q4 2021

Feb 07, 2022
BUY
$70.09 - $111.29 $5,186 - $8,235
74 Added 18.69%
470 $36,000
Q3 2021

Nov 02, 2021
SELL
$110.2 - $156.64 $1,542 - $2,192
-14 Reduced 3.41%
396 $44,000
Q2 2021

Aug 11, 2021
SELL
$100.84 - $161.89 $6,857 - $11,008
-68 Reduced 14.23%
410 $66,000
Q1 2021

May 14, 2021
SELL
$110.72 - $210.04 $7,418 - $14,072
-67 Reduced 12.29%
478 $58,000
Q4 2020

Feb 16, 2021
SELL
$79.67 - $173.23 $18,563 - $40,362
-233 Reduced 29.95%
545 $83,000
Q3 2020

Nov 16, 2020
BUY
$78.5 - $100.64 $3,768 - $4,830
48 Added 6.58%
778 $65,000
Q1 2020

May 07, 2020
BUY
$33.68 - $62.53 $3,671 - $6,815
109 Added 17.55%
730 $31,000
Q4 2019

Feb 06, 2020
BUY
$36.68 - $73.13 $1,980 - $3,949
54 Added 9.52%
621 $38,000
Q3 2019

Nov 05, 2019
BUY
$40.99 - $52.56 $860 - $1,103
21 Added 3.85%
567 $23,000
Q2 2019

Aug 08, 2019
BUY
$35.45 - $48.2 $9,500 - $12,917
268 Added 96.4%
546 $26,000
Q1 2019

May 15, 2019
BUY
$28.02 - $40.87 $7,789 - $11,361
278 New
278 $10,000

Others Institutions Holding CRSP

# of Institutions
523
Shares Held
58M
Call Options Held
1.73M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.87B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email